ACE2 and COVID-19: Of note, ACE2 cellular density or availability is determinant in maintaining normal tissue homeostasis, thus, ACE2 activators or soluble form of recombinant human ACE2 have been suggested to treat COVID-19 patients [16,17,18,19].